Clinical Trials on Alopecia Areata in Norway

Total 3 results

Concert Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2) (THRIVE-AA2)

Alopecia Areata

Spain, United States, Poland, Canada, France, Germany, Hungary
Concert Pharmaceuticals

Active, not recruiting

European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

Alopecia Areata

Spain, Germany, Poland, France, Hungary
Oslo University Hospital

Completed

MRI Study After Arterial Switch Operation in Patients With Transposition of the Great Arteries

Surgery | Transposition of Great Vessels

Norway

3

Subscribe